STAT

MARCH 19, 2024

The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease. Except scientific research doesn’t say that — and not only should you not be worried about this study, you shouldn’t be wasting brain glucose thinking about it.

364

364

PharmaVoice

MARCH 19, 2024

Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.

Vaccines 246

Vaccines 246

STAT

MARCH 19, 2024

Since colorectal cancer is on the rise in people younger than age 50, national guidelines have recently pushed the starting age for colorectal cancer screening down to 45. We need to spread the word. Yet we specialists continue to provide outdated and disproven recommendations on colonoscopy bowel preparation that make the process more difficult for the millions of patients who undergo colonoscopy every year: We tell them to adopt a clear liquid diet the day before their procedure.

364

364

The Pharmacist

MARCH 19, 2024

Almost a third of Pharmacy First consultations carried out by members of the Company Chemists’ Association (CCA) within the first month of the service were provided in the 20% most deprived communities, new data has suggested. Data from the CCA has this week revealed that ‘just over 3,000’ member pharmacies delivered 48,195 Pharmacy First consultations […] The post CCA: Third of Pharmacy First consultations in 20% most deprived communities appeared first on The Pharmacist.

126

126

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 19, 2024

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer. AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday.

Drug Development 295

Drug Development 295

PharmaVoice

MARCH 19, 2024

A rebound in M&A seems to be on the docket, but analysts are warning companies to be intentional about where they go with it.

125

125

The Pharmacist

MARCH 19, 2024

Two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) produced by Besins Healthcare (UK) Ltd have been recalled from pharmacies over issues with the pump mechanism. More than one in 10 (11%) of the pumps within these batches may be faulty, resulting in failure to dispense the product and in some cases the pump becoming […] The post Oestrogel recalled from pharmacies over faulty pump appeared first on The Pharmacist.

92

92

STAT

MARCH 19, 2024

Nobody has made more of an impact on methadone treatment than Mark Parrino. For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

270

270

The Pharmacist

MARCH 19, 2024

The Department of Health and Social Care (DHSC) has acknowledged multiple ‘high impact’ supply issues with several types of glucagon-like peptide-1 receptor agonists (GLP1-RAs). This week it has issued a ‘high impact’ medicine supply notification for several drugs used to treat type 2 diabetes and weight loss, including: Semaglutide (Ozempic) 0.25mg, 0.5mg and 1mg solution […] The post Notification issued for multiple GLP1-RA shortages appeared first on The Pharmacist.

Diabetes 99

Diabetes 99

STAT

MARCH 19, 2024

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.  The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD.

Medical Schools 270

Medical Schools Hospitals 270

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

MARCH 19, 2024

Learn how AI and enhanced medical affairs roles are transforming the landscape of drug development and patient engagement in the health industry. Explore the benefits and advancements in this exciting field.

Drug Development 109

Drug Development 109

STAT

MARCH 19, 2024

Rise and shine, everyone, another busy day is on the way. Already, the official mascots are racing about the Pharmalot campus in search of breakfast and a steady stream of traffic can be heard nearby. As for us, we are engaged in the usual rituals, starting with brewing cups of stimulation. Our choice today is salted caramel, a veritable whiff of the Jersey shore.

244

244

Pharmaceutical Commerce

MARCH 19, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

105

105

STAT

MARCH 19, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a pioneering new gene therapy, the plight of WuXi AppTec, and a rough month for biotech’s neuroscience renaissance.

205

205

Digital Pharmacist

MARCH 19, 2024

Younger patients are already beginning to dictate the course of modern healthcare, yet they are rarely the focus of pharmacies’ marketing efforts. Their focus on holistic health and lifestyle-based solutions have contributed to an emphasis on mental health and to recent upticks in organic and wellness trends. Pharmacies can take a long-term approach to marketing by closely looking at who their younger patients are and what they need from their local pharmacy.

104

104

pharmaphorum

MARCH 19, 2024

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too.

102

102

PioneerRx

MARCH 19, 2024

Pharmacy work is demanding. One minute you’re at the drive thru. The next, you’re answering phone calls or submitting vaccination claims. A day in the pharmacy.

Vaccines 105

Vaccines 105

pharmaphorum

MARCH 19, 2024

Discover the key strategies for managing the challenges and embracing the opportunities of EU-wide Health Technology Assessment (HTA) in partnership with the European Medicines Agency (EMA) and prospective market authorisation holders (pMAHs).

99

99

Express Pharma

MARCH 19, 2024

Orchard, which was acquired by Japanese pharmaceutical firm Kyowa Kirin for $477.6 million last year, said it will provide details on the pricing and availability of the therapy later in the week The U.S. health regulator on Monday approved UK-based Orchard Therapeutics’ gene therapy to treat children with metachromatic leukodystrophy (MLD), making it the first approved treatment in the United States for the rare, hereditary disease.

Labelling 101

Labelling 101

European Pharmaceutical Review

MARCH 19, 2024

Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. As part of this new agreement, Novartis has exercised its option to acquire all outstanding capital stock of IFM Due, a subsidiary company of IFM. Therefore, under the acquisition, Novartis has full rights to IFM Due’s portfolio of small molecule Stimulator of Interferon Genes (STING) antagonists, IFM confirmed.

Immunity 98

Immunity Immunization 98

Express Pharma

MARCH 19, 2024

The deal is AstraZeneca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio AstraZeneca said on Tuesday it will buy clinical stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments.

Chemotherapy 99

Chemotherapy 99

Pharmaceutical Technology

MARCH 19, 2024

In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.

112

112

pharmaphorum

MARCH 19, 2024

Do better: The message to the industry from an analysis of clinical evidence submitted to NICE over 20 years Mike.

115

115

Express Pharma

MARCH 19, 2024

In this episode of the Express Pharma – Nutrify Today Boardroom series, Suresh Garg, Founder & CMD, Zeon Lifesciences draws upon more than three decades of experience spanning nutrition, dairy products, healthcare, and nutraceuticals, to give insights on how companies like Zeon Lifesciences can achieve success in the global nutraceutical arena.

88

88

pharmaphorum

MARCH 19, 2024

AstraZeneca upgrades its radiopharma alliance with Fusion Pharma, opting to buy the biotech outright in a deal worth around $2 billion

99

99

The Pharmacist

MARCH 19, 2024

European health officials have reported a ‘troubling surge’ in sexually transmitted infections (STI), with gonorrhoea cases rising by almost half. The European Centre for Disease Prevention and Control (ECDC) said there had also been a significant increase in cases of syphilis and chlamydia. A report reviewing STI infections in Europe in 2022 found that the number […] The post Europe sees ‘troubling rise’ in STIs including gonorrhoea appeared first on The Pharmacist.

81

81

pharmaphorum

MARCH 19, 2024

New phase 3 data sets up filings for Bayer's non-hormonal menopause symptom treatment elinzanetant and a challenge to Astellas’ first-to-market Veozah

90

90

Pharmaceutical Technology

MARCH 19, 2024

The new initiative aims to spur innovation and mobilisation of sectors to drive women’s health research.

111

111

Express Pharma

MARCH 19, 2024

DP World has inaugurated the latest in a string of more than 100 freight forwarding offices across the world. A company statement informed that the offices employ 1,000 staff, adding to DP World’s existing 108,000-strong team and this is expected to grow significantly over the next 12 months, helping move more than 10 per cent of global trade every year.

84

84

Pharmaceutical Technology

MARCH 19, 2024

The US FDA has granted approval to Orchard Therapeutics' Lenmeldy for specific forms of metachromatic leukodystrophy (MLD).

98

98

Outsourcing Pharma

MARCH 19, 2024

With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug Administration (FDA) has taken proactive steps to outline a comprehensive strategy for regulating AI in medical products.

80

80

pharmaphorum

MARCH 19, 2024

Johnson & Johnson has allied with NVIDIA to bring artificial intelligence into operating rooms and accelerate the adoption of digital tech in surgery

83

83

Drug Channels

MARCH 19, 2024

I am pleased to announce our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers’ (press release) Review pricing/license options and download the full 2024 report We’re offering special discounted pric

Drug Pricing 70

Drug Pricing 70

European Pharmaceutical Review

MARCH 19, 2024

According to research by InsightAce Analytic Pvt. Ltd., the global continuous bioprocessing market is expected to value $1,067.8 million by 2031. While the market was valued at $255.9 million in 2023, the report predicted it will witness a CAGR of 19.72 percent between 2024-2031. The research explained that companies are looking to reduce manufacturing costs and increase productivity, which is driving implementation of this type of bioprocessing.

Documentation 70

Documentation 70

World Pharma News

MARCH 19, 2024

A new cancer treatment that uses a person’s own immune cells has been approved by the U.S. Food and Drug Administration (FDA) for treating the most dangerous type of skin cancer. Now this form of cellular therapy (tumor-infiltrating lymphocyte - or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway at The Ohio State University Comprehensive Cancer Center - Arthur G.

Immunity 75

Immunity Immunization Hospitals 75